2022 ICD-10-CM Code H35.32

Exudative age-related macular degeneration

Version 2021

Not Valid for Submission

ICD-10:H35.32
Short Description:Exudative age-related macular degeneration
Long Description:Exudative age-related macular degeneration

Code Classification

  • Diseases of the eye and adnexa (H00–H59)
    • Disorders of choroid and retina (H30-H36)
      • Other retinal disorders (H35)

H35.32 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of exudative age-related macular degeneration. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

Specific Coding for Exudative age-related macular degeneration

Non-specific codes like H35.32 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for exudative age-related macular degeneration:

  • NON-BILLABLE CODE - H35.321 for Exudative age-related macular degeneration, right eye
  • BILLABLE CODE - Use H35.3210 for stage unspecified
  • BILLABLE CODE - Use H35.3211 for with active choroidal neovascularization
  • BILLABLE CODE - Use H35.3212 for with inactive choroidal neovascularization
  • BILLABLE CODE - Use H35.3213 for with inactive scar
  • NON-BILLABLE CODE - H35.322 for Exudative age-related macular degeneration, left eye
  • BILLABLE CODE - Use H35.3220 for stage unspecified
  • BILLABLE CODE - Use H35.3221 for with active choroidal neovascularization
  • BILLABLE CODE - Use H35.3222 for with inactive choroidal neovascularization
  • BILLABLE CODE - Use H35.3223 for with inactive scar
  • NON-BILLABLE CODE - H35.323 for Exudative age-related macular degeneration, bilateral
  • BILLABLE CODE - Use H35.3230 for stage unspecified
  • BILLABLE CODE - Use H35.3231 for with active choroidal neovascularization
  • BILLABLE CODE - Use H35.3232 for with inactive choroidal neovascularization
  • BILLABLE CODE - Use H35.3233 for with inactive scar
  • NON-BILLABLE CODE - H35.329 for Exudative age-related macular degeneration, unspecified eye
  • BILLABLE CODE - Use H35.3290 for stage unspecified
  • BILLABLE CODE - Use H35.3291 for with active choroidal neovascularization
  • BILLABLE CODE - Use H35.3292 for with inactive choroidal neovascularization
  • BILLABLE CODE - Use H35.3293 for with inactive scar

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code H35.32:


Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

7th Character Note

7th Character Note
Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.

7th Character

7th Character
Indicates that a seventh character is to be assigned to codes in a subcategory.

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code H35.32 are found in the index:

Information for Patients


Macular Degeneration

Macular degeneration, or age-related macular degeneration (AMD), is a leading cause of vision loss in Americans 60 and older. It is a disease that destroys your sharp, central vision. You need central vision to see objects clearly and to do tasks such as reading and driving.

AMD affects the macula, the part of the eye that allows you to see fine detail. It does not hurt, but it causes cells in the macula to die. There are two types: wet and dry. Wet AMD happens when abnormal blood vessels grow under the macula. These new blood vessels often leak blood and fluid. Wet AMD damages the macula quickly. Blurred vision is a common early symptom. Dry AMD happens when the light-sensitive cells in the macula slowly break down. Your gradually lose your central vision. A common early symptom is that straight lines appear crooked.

Regular comprehensive eye exams can detect macular degeneration before the disease causes vision loss. Treatment can slow vision loss. It does not restore vision.

NIH: National Eye Institute


[Learn More in MedlinePlus]

Age-related macular degeneration

Age-related macular degeneration is an eye disease that is a leading cause of vision loss in older people in developed countries. Subtle abnormalities indicating changes in vision may occur in a person's forties or fifties. Distorted vision and vision loss usually become noticeable in a person's sixties or seventies and tend to worsen over time.

Age-related macular degeneration mainly affects central vision, which is needed for detailed tasks such as reading, driving, and recognizing faces. The vision loss in this condition results from a gradual deterioration of light-sensing cells in the tissue at the back of the eye that detects light and color (the retina). Specifically, age-related macular degeneration affects a small area near the center of the retina, called the macula, which is responsible for central vision. Side (peripheral) vision and night vision are generally not affected, but slow adjustment of vision to darkness (dark adaptation) and reduced dim light (scotopic) vision often occur in the early stages of the disease.

Researchers have described two major types of age-related macular degeneration, known as the dry form and the wet form. The dry form is much more common, accounting for 85 to 90 percent of all cases of age-related macular degeneration. It is characterized by a buildup of yellowish deposits called drusen beneath the retina and vision loss that worsens slowly over time. The most advanced stage of dry age-related macular degeneration is known as geographic atrophy, in which areas of the macula waste away (atrophy), resulting in severe vision loss. Dry age-related macular degeneration typically affects vision in both eyes, although vision loss often occurs in one eye before the other.

In 10 to 15 percent of affected individuals, the dry form progresses to the wet form of age-related macular degeneration. The wet form is characterized by the growth of abnormal, fragile blood vessels underneath the macula. These vessels leak blood and fluid, which damages the macula and makes central vision appear blurry and distorted. The wet form of age-related macular degeneration is associated with severe vision loss that can worsen rapidly.


[Learn More in MedlinePlus]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)